MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1341 to 1360 of 166,322 approvalsPage 68 of 8317

Ambroxol Hydrochloride Solution for Inhalation

Approval Number: 国药准字H20253465
Registration: Feb 25, 2025

Pentoxifylline Injection

Approval Number: 国药准字H20253452
Registration: Feb 25, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253458
Registration: Feb 25, 2025

Febuxostat Tablets

Approval Number: 国药准字H20253470
Registration: Feb 25, 2025

Polyethylene Glycol Electrolytes Powder(III)

Approval Number: 国药准字H20253477
Registration: Feb 25, 2025

Levetiracetam Oral Solution

Approval Number: 国药准字H20253467
Registration: Feb 25, 2025

Acarbose Tablets

Approval Number: 国药准字H20253463
Registration: Feb 25, 2025

Iomeprol Injection

Approval Number: 国药准字H20253479
Registration: Feb 25, 2025

Lacosamide Injection

Approval Number: 国药准字H20253468
Registration: Feb 25, 2025

Botulinum Toxin Type A for Injection

Approval Number: 国药准字SJ20200016
Registration: Feb 25, 2025

Drotaverine Hydrochloride Injection

Approval Number: 国药准字H20253456
Registration: Feb 25, 2025

Fluvoxamine Maleate Tablets

Approval Number: 国药准字H20253471
Registration: Feb 25, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253473
Registration: Feb 25, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253457
Registration: Feb 25, 2025

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20253445
Registration: Feb 25, 2025

Ibuprofen Suspension

Approval Number: 国药准字H20253472
Registration: Feb 25, 2025

Iron Proteinsuccinylate Oral Solution

Approval Number: 国药准字H20253461
Registration: Feb 25, 2025

Phloroglucinol Injection

Approval Number: 国药准字H20253475
Registration: Feb 25, 2025

Lacosamide Injection

Approval Number: 国药准字H20253469
Registration: Feb 25, 2025

Mycophenolate Mofetil For Suspension

Approval Number: 国药准字H20253453
Registration: Feb 25, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.